XML 17 R7.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Retained Earnings (Deficit)
Accumulated Other Comprehensive Income (Loss)
Treasury Stock
Noncontrolling Interest
Beginning Balance at Dec. 31, 2022 $ 1,665,523 $ 3,023 $ 3,202,973 $ (87,394) $ 0 $ (1,453,079) $ 0
Beginning Balance (in shares) at Dec. 31, 2022   302,326,000          
Net income (loss) 99,678     99,678      
Vesting of restricted stock units 0 $ 1 (1)        
Vesting of restricted stock units (in shares)   89,000          
Stock-based compensation (758)   (758)        
Payment of cash dividends (16,916)     (16,916)      
Dividend equivalents (263)     (263)      
Purchase of treasury stock (74,307)         (74,307)  
Ending Balance at Mar. 31, 2023 1,672,957 $ 3,024 3,202,214 (4,895) 0 (1,527,386) 0
Ending Balance (in shares) at Mar. 31, 2023   302,415,000          
Beginning Balance at Dec. 31, 2022 1,665,523 $ 3,023 3,202,973 (87,394) 0 (1,453,079) 0
Beginning Balance (in shares) at Dec. 31, 2022   302,326,000          
Net income (loss) 184,014            
Foreign currency translation adjustment (656)            
Ending Balance at Sep. 30, 2023 4,859,614 $ 5,158 6,395,867 28,921 (656) (1,578,077) 8,401
Ending Balance (in shares) at Sep. 30, 2023   515,845,000          
Beginning Balance at Mar. 31, 2023 1,672,957 $ 3,024 3,202,214 (4,895) 0 (1,527,386) 0
Beginning Balance (in shares) at Mar. 31, 2023   302,415,000          
Net income (loss) 84,614     84,614      
Issuance of restricted stock 0 $ 10 (10)        
Issuance of restricted stock (in shares)   1,001,000          
Vesting of restricted stock units 0 $ 15 (15)        
Vesting of restricted stock units (in shares)   1,512,000          
Stock-based compensation 6,738   6,738        
Payment of cash dividends (16,591)     (16,591)      
Dividend equivalents (229)     (229)      
Purchase of treasury stock (27,320)         (27,320)  
Ending Balance at Jun. 30, 2023 1,720,169 $ 3,049 3,208,927 62,899 0 (1,554,706) 0
Ending Balance (in shares) at Jun. 30, 2023   304,928,000          
Net income (loss) (278)     50     (328)
Noncontrolling interest 8,729           8,729
Foreign currency translation adjustment (656)       (656)    
Issuance of common stock - Ulterra acquisition 521,406 $ 349 521,057        
Issuance of common stock - Ulterra acquisition (in shares)   34,900,000          
Issuance of common stock - NexTier merger 2,567,872 $ 1,722 2,566,150        
Issuance of common stock - NexTier merger (in shares)   172,224,000          
Issuance of replacement awards related to NexTier merger 72,413   72,413        
Vesting of restricted stock units 0 $ 38 (38)        
Vesting of restricted stock units (in shares)   3,793,000          
Stock-based compensation 27,358   27,358        
Payment of cash dividends (33,217)     (33,217)      
Dividend equivalents (811)     (811)      
Purchase of treasury stock (23,371)         (23,371)  
Ending Balance at Sep. 30, 2023 4,859,614 $ 5,158 6,395,867 28,921 (656) (1,578,077) 8,401
Ending Balance (in shares) at Sep. 30, 2023   515,845,000          
Beginning Balance at Dec. 31, 2023 $ 4,820,681 $ 5,166 6,407,294 57,035 472 (1,657,675) 8,389
Beginning Balance (in shares) at Dec. 31, 2023 516,775,313 516,775,000          
Net income (loss) $ 51,706     51,235     471
Foreign currency translation adjustment (993)            
Vesting of restricted stock units 0 $ 14 (14)        
Vesting of restricted stock units (in shares)   1,363,000          
Stock-based compensation 12,051   12,051        
Payment of cash dividends (32,553)     (32,553)      
Dividend equivalents (422)     (422)      
Purchase of treasury stock (98,613)         (98,613)  
Ending Balance at Mar. 31, 2024 4,751,857 $ 5,180 6,419,331 75,295 (521) (1,756,288) 8,860
Ending Balance (in shares) at Mar. 31, 2024   518,138,000          
Beginning Balance at Dec. 31, 2023 $ 4,820,681 $ 5,166 6,407,294 57,035 472 (1,657,675) 8,389
Beginning Balance (in shares) at Dec. 31, 2023 516,775,313 516,775,000          
Net income (loss) $ (915,007)            
Foreign currency translation adjustment (523)            
Ending Balance at Sep. 30, 2024 $ 3,571,958 $ 5,207 6,443,043 (956,173) (51) (1,929,899) 9,831
Ending Balance (in shares) at Sep. 30, 2024 520,742,360 520,742,000          
Beginning Balance at Mar. 31, 2024 $ 4,751,857 $ 5,180 6,419,331 75,295 (521) (1,756,288) 8,860
Beginning Balance (in shares) at Mar. 31, 2024   518,138,000          
Net income (loss) 11,621     11,077     544
Foreign currency translation adjustment (127)       (127)    
Issuance of restricted stock 0 $ 8 (8)        
Issuance of restricted stock (in shares)   719,000          
Vesting of restricted stock units 0 $ 17 (17)        
Vesting of restricted stock units (in shares)   1,647,000          
Stock-based compensation 10,813   10,813        
Payment of cash dividends (31,815)     (31,815)      
Dividend equivalents (348)     (348)      
Purchase of treasury stock (133,487)         (133,487)  
Ending Balance at Jun. 30, 2024 4,608,514 $ 5,205 6,430,119 54,209 (648) (1,889,775) 9,404
Ending Balance (in shares) at Jun. 30, 2024   520,504,000          
Net income (loss) (978,334)     (978,761)     427
Foreign currency translation adjustment 597       597    
Vesting of restricted stock units 0 $ 2 (2)        
Vesting of restricted stock units (in shares)   238,000          
Stock-based compensation 12,926   12,926        
Payment of cash dividends (31,225)     (31,225)      
Dividend equivalents (396)     (396)      
Purchase of treasury stock (40,124)         (40,124)  
Ending Balance at Sep. 30, 2024 $ 3,571,958 $ 5,207 $ 6,443,043 $ (956,173) $ (51) $ (1,929,899) $ 9,831
Ending Balance (in shares) at Sep. 30, 2024 520,742,360 520,742,000